Nancy S Green
Affiliation: Columbia University
- Candidate sequence variants and fetal hemoglobin in children with sickle cell disease treated with hydroxyureaNancy S Green
Department of Pediatrics, Columbia University, New York, New York, USA
PLoS ONE 8:e55709. 2013..The sole approved pharmacologic therapy for this disease is hydroxyurea, with effects largely attributable to induction of fetal hemoglobin...
- Genetic modifiers of HbF and response to hydroxyurea in sickle cell diseaseNancy S Green
Department of Pediatrics, Columbia University Medical Center, New York, New York 10032, USA
Pediatr Blood Cancer 56:177-81. 2011..We review these methods and findings, and speculate on applying pharmaco-genetics to optimize hydroxyurea therapy aimed at increasing HbF...
- Parental and other factors associated with hydroxyurea use for pediatric sickle cell diseaseSuzette O Oyeku
Department of Pediatrics, Division of General Pediatrics, Children s Hospital at Montefiore, Albert Einstein College of Medicine of Yeshiva University, Bronx, New York 10467, USA
Pediatr Blood Cancer 60:653-8. 2013..Hydroxyurea (HU) is highly effective treatment for sickle cell disease (SCD). While pediatric use of HU is accepted clinical practice, barriers to use may impede its potential benefit...
- Fetal hemoglobin levels in African American and Hispanic children with sickle cell disease at baseline and in response to hydroxyureaKatherine L Ender
Pediatric Hematology, Columbia University Medical Center, NY 10032, USA
J Pediatr Hematol Oncol 33:496-9. 2011..If generalizable, our results support combining these 2 groups in future clinical and translational analyses focused on HbF and response to HU in this ethnically mixed patient population...
- Incomplete follow-up of hemoglobinopathy carriers identified by newborn screening despite reporting in electronic medical recordsMara Burney
School of Nursing, Columbia University Medical Center, New York, New York 10032, USA
J Natl Med Assoc 103:852-6. 2011..Has the recent availability of newborn hemoglobinopathy screening results within patient electronic medical records (EMR) of birth hospitals facilitated follow-up by primary care pediatric providers?..
- A framework for key considerations regarding point-of-care screening of newbornsAlex R Kemper
Department of Pediatrics, Duke University, Durham, North Carolina, USA
Genet Med 14:951-4. 2012....
- Awareness of sickle cell among people of reproductive age: Dominicans and African Americans in northern ManhattanSaira Siddiqui
Department of Pediatrics, Columbia University, 622 W 168th St, Rm VC4 412, New York, NY 10032, USA
J Urban Health 89:53-8. 2012..Y.C. community affected by sickle conditions frequently lack basic relevant information, with larger information gaps among Dominicans. Expanded efforts are warranted to inform young adults of diverse affected communities...